Subcutaneous golimumab induced and maintained clinical response in a child with a biological-experienced steroid-refractory flare of ulcerative colitis: A case report

INTRODUCTION: Golimumab is a fully human antitumor necrosis monoclonal antibody that can be administered by either subcutaneous injection or intravenous infusion. Golimumab is approved for the treatment of the adults with rheumatic diseases, and ulcerative colitis, Whereas in children, golimumab is...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhalabi, Marouf, Eddin, Kamal Alaa, Cheha, Khaled, Abbas, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462589/
https://www.ncbi.nlm.nih.gov/pubmed/34559136
http://dx.doi.org/10.1097/MD.0000000000027283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462589/
https://www.ncbi.nlm.nih.gov/pubmed/34559136
http://dx.doi.org/10.1097/MD.0000000000027283

Ejemplares similares